Underdog Pharmaceuticals Company

Underdog develops interventions targeting toxic forms of cholesterol to provide true disease-modifying treatments for age-related diseases.

Last Funding Type: Seed
Funding Status: Seed
Headquarters: Mountain View, California, United States
Founded Date: 2019
Last Funding Date: 2019
Total Funding: 4000000
Employee Number: 1-10
Investors Number: 4
Industry: Pharmaceutical